Results for barbital
On this page:
 
Dictionary:

barbital

  (bär'bĭ-tôl', -tăl') pronunciation
n.

A barbiturate, C8H12N2O3, that is a white crystalline powder and is used as a sedative and hypnotic especially in the form of its soluble salt, sodium barbital.

[BARBIT(URIC ACID) + –AL3.]


 
 
Medical Dictionary: bar·bi·tal
(bär'bĭ-tôl', -tăl')
n.

A white crystalline barbiturate used as a sedative and hypnotic, especially in the form of its soluble salt, sodium barbital.

 
WordNet: barbital
Note: click on a word meaning below to see its connections and related words.

The noun has one meaning:

Meaning #1: a barbiturate used as a hypnotic
  Synonyms: veronal, barbitone, diethylbarbituric acid, diethylmalonylurea


 
Wikipedia: barbital
Barbital.svg
Barbital
Systematic (IUPAC) name
5,5-diethyl-1,3-diazinane-2,4,6-trione Ethylbarbital
Identifiers
CAS number 57-44-3
ATC code N05CA04
PubChem 2294
DrugBank ?
Chemical data
Formula C8H12N2O3 
Mol. mass 184.193 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status

?

Routes Oral

Barbital (marketed under the brand name Veronal), also called barbitone, was the first commercially marketed barbiturate. It was used as a sleeping aid (hypnotic) from 1903 until the mid-1950s. The chemical names for barbital are diethylmalonyl urea or diethylbarbituric acid. Its chemical formula is (C2H5)2C~CO NH]ICO (sodium 5,5-diethyl barbiturate). Veronal was prepared by condensing diethylmalonic ester with urea in the presence of sodium ethylate, or by adding ethyl iodide to the silver salt of malonylurea. The result was an odorless, slightly bitter, white crystalline powder.

Barbital was first synthesized in 1902 by German chemists Emil Fischer and Joseph von Mering. They published their discovery in 1903 and it was marketed in 1904 by the Bayer company as “Veronal”. A soluble salt of barbital was marketed by the Schering company as “Medinal.” It was dispensed for “insomnia induced by nervous excitability”. [1] It was provided in either capsules or cachets. The therapeutic dose was ten to fifteen grains (0.65-0.97 grams). 3.5 to 4.4 grams is the deadly dose but sleep has also been prolonged up to ten days with recovery.

Veronal was considered to be a great improvement over the existing hypnotics. Its taste was slightly bitter, but an improvement over the strong, unpleasant taste of the commonly used bromides. It had few side effects. Its therapeutic dose was far below the toxic dose. However, prolonged usage resulted in tolerance to the drug, requiring higher doses to reach the desired effect. Fatal overdoses of this slow acting hypnotic were not uncommon.

References

  • Fischer, Emil and Joseph von Mering, “Ueber eine neue Klasse von Schlafmitteln”, Therap Gegenw 44:97-101, 1903.
  • "Veronal", in Finley, Ellingwood, M.D. The American Materia Medica, Therapeutics and Pharmacognosy", 1919. [2], accessed 07 Nov 2005.
  • "Emma Zunz" by Jorge Luis Borges (short story)


This article incorporates text from the Encyclopædia Britannica Eleventh Edition, a publication now in the public domain.


 
 

Join the WikiAnswers Q&A community. Post a question or answer questions about "barbital" at WikiAnswers.

 

Copyrights:

Dictionary. The American Heritage® Dictionary of the English Language, Fourth Edition Copyright © 2007, 2000 by Houghton Mifflin Company. Updated in 2007. Published by Houghton Mifflin Company. All rights reserved.  Read more
Medical Dictionary. The American Heritage® Stedman's Medical Dictionary Copyright © 2002, 2001, 1995 by Houghton Mifflin Company Read more
WordNet. WordNet 1.7.1 Copyright © 2001 by Princeton University. All rights reserved.  Read more
Wikipedia. This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Barbital" Read more

Search for answers directly from your browser with the FREE Answers.com Toolbar!  
Click here to download now. 

Get Answers your way! Check out all our free tools and products.

On this page:   E-mail   print Print  Link  

 

Keep Reading

Mentioned In: